Market Outlook

By 2035, the U.S. Wearable Neurology Devices Market is expected to reach approximately USD 13.31 billion, expanding at a CAGR of 15.39% during the forecast period 2026–2035. The market was valued at approximately USD 3.18 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. wearable neurology devices industry is transitioning from a collection of niche monitoring products into a clinically relevant digital neurology ecosystem. The market includes wearable electroencephalography systems, ambulatory seizure-detection devices, tremor and gait-monitoring wearables, non-invasive neuromodulation systems, neurorehabilitation wearables, head-mounted neural sensing platforms, cognitive monitoring devices, and software-connected sensor systems used to measure neurological function outside conventional clinical environments.

Demand is being shaped by the large and rising burden of epilepsy, Parkinson’s disease, essential tremor, migraine, stroke-related disability, traumatic brain injury, Alzheimer’s disease, sleep-related neurological disorders, and other chronic neurological conditions. Approximately 3 million U.S. adults have active epilepsy, more than 1 million people are living with Parkinson’s disease, and an estimated 7.2 million Americans aged 65 and older had Alzheimer’s dementia in 2025. The U.S. also records more than 200,000 traumatic brain injury-related hospitalizations in a typical reported year, while migraine or severe headache affects a substantial share of the working-age population.

These conditions create a strong need for continuous and objective data that cannot be captured through episodic office examinations alone. Traditional neurology evaluations frequently depend on patient recall, caregiver observations, clinical scales, short-duration electroencephalography, and periodic specialist visits. Wearable devices address this limitation by measuring seizure-associated physiological activity, movement fluctuation, gait instability, tremor amplitude, sleep disruption, cognitive performance, rehabilitation progress, medication response, and other digital neurological biomarkers in real-world settings.

The historical market expanded from approximately USD 1.78 billion in 2021 to USD 2.72 billion in 2024. Market revenue reached an estimated USD 2.04 billion in 2022 and USD 2.35 billion in 2023. Growth during this period was supported by wider adoption of remote neurological monitoring, decentralized clinical trials, wearable EEG systems, app-controlled migraine therapies, home-based rehabilitation platforms, and movement-disorder monitoring technologies.

In 2025, the market increased to approximately USD 3.18 billion as FDA-cleared seizure-monitoring wearables, extended-wear EEG sensors, prescription tremor-relief devices, and digitally connected neuromodulation systems gained greater commercial visibility. Hospital neurology departments, epilepsy centers, movement-disorder clinics, rehabilitation providers, pharmaceutical companies, and home-care programs increased their evaluation of wearable neurological data as a supplement to conventional clinical assessments.

The market is projected to exceed USD 6.50 billion by 2030 before reaching USD 13.31 billion in 2035. Growth will not be driven by hardware sales alone. Recurring software subscriptions, disposable sensors, cloud-based interpretation, patient-management services, algorithm upgrades, remote review platforms, and research-data contracts will represent an increasing portion of supplier revenue.

The market figures presented in this report are analyst-derived estimates based on U.S. device commercialization, installed systems, wearable unit utilization, disposable and replacement components, software subscriptions, clinical research use, remote monitoring services, and manufacturer participation. General-purpose consumer fitness wearables are excluded unless deployed through a defined neurological monitoring or therapeutic workflow. Implantable neurostimulation systems and conventional fixed neurological imaging equipment are also excluded.

 

Introduction

According to the U.S. Wearable Neurology Devices Market Report, wearable neurotechnology is becoming an important bridge between the neurological examination performed in a controlled clinical setting and the patient’s actual experience at home, at work, during sleep, and throughout daily activities. This distinction is strategically important because many neurological symptoms fluctuate over time and may not be visible during a scheduled consultation.

A patient with Parkinson’s disease may show acceptable mobility during a clinic visit while experiencing substantial bradykinesia, freezing, tremor, or medication “off” periods during the remainder of the day. A patient with epilepsy may be unable to accurately document nocturnal or unwitnessed seizures. A person undergoing stroke rehabilitation may demonstrate progress in supervised therapy but use the affected limb less frequently at home. Migraine frequency, sleep disturbance, gait instability, and cognitive decline similarly require longitudinal rather than episodic assessment.

Wearable neurology devices convert these real-world observations into measurable physiological and behavioral information. Depending on the platform, the device may capture electroencephalographic signals, accelerometry, angular velocity, electrodermal activity, heart rate, skin temperature, muscle activity, pressure distribution, posture, sleep patterns, speech characteristics, upper-limb use, or digital interaction data. Algorithms can subsequently identify clinically relevant patterns, summarize symptom burden, issue caregiver alerts, or support clinician review.

The U.S. is particularly attractive for wearable neurology manufacturers because it combines a large neurological patient population with advanced academic centers, established epilepsy-monitoring units, specialist movement-disorder programs, rehabilitation networks, digital-health investment, pharmaceutical research activity, and a comparatively receptive environment for high-value medical technology. The country has more than 6,000 hospitals and approximately 900,000 staffed hospital beds, providing a large clinical infrastructure through which wearable devices can be prescribed, validated, deployed, or incorporated into post-discharge care.

The commercial structure of the market differs materially from conventional capital-equipment categories. A wearable neurology platform may generate revenue from the initial device, recurring sensors, electrodes, armbands, consumable cartridges, software access, cloud storage, clinician dashboards, technical support, data interpretation, and research services. This creates the potential for predictable recurring revenue, but it also requires manufacturers to maintain high patient adherence, reliable connectivity, cybersecurity, clinical support, and software performance.

Hospital and health-system procurement decisions are increasingly based on whether a wearable platform solves a defined operational problem. Neurology leaders are unlikely to purchase devices solely because they generate additional data. The data must change patient selection, reduce diagnostic uncertainty, support faster treatment adjustment, prevent avoidable utilization, improve rehabilitation decisions, or enable specialist oversight across a wider patient population.

For manufacturers, the critical commercialization challenge is therefore workflow conversion. A device may demonstrate acceptable signal accuracy in a clinical trial but still fail commercially if it produces excessive alerts, requires burdensome data review, depends on unreliable patient pairing, or cannot integrate with the neurologist’s existing workflow. Successful platforms convert complex sensor output into concise and actionable clinical information.

From 2026 through 2035, the strategic direction of the market will move toward multimodal sensing, artificial intelligence-supported interpretation, condition-specific digital biomarkers, individualized stimulation protocols, and closed-loop neurological management. Device companies able to combine clinically validated hardware, regulatory-grade software, interoperable data infrastructure, reimbursement support, and specialty-care implementation will be positioned more favorably than suppliers offering isolated sensors.

 

Key Market Drivers: What’s Fueling the U.S. Wearable Neurology Devices Market Boom?

The first major driver is the scale of chronic neurological disease in the United States. Active epilepsy affects approximately 3 million adults, with an additional pediatric population requiring ongoing seizure management. Parkinson’s disease affects more than 1 million Americans, and approximately 90,000 new cases are diagnosed annually. Alzheimer’s dementia affected an estimated 7.2 million Americans aged 65 and older in 2025. These populations create a substantial addressable market for long-duration monitoring, caregiver alerts, medication-response measurement, fall-risk assessment, sleep monitoring, and home-based neurological management.

A second driver is the clinical limitation of snapshot-based neurological assessment. Many neurological conditions are variable, episodic, or strongly influenced by the patient’s environment. Seizures may occur during sleep. Tremor may worsen during specific tasks. Parkinsonian symptoms may fluctuate according to medication timing. Gait instability may emerge under fatigue or dual-task conditions. Wearable monitoring provides repeated measurements across hours, days, or weeks, allowing clinicians to examine symptom patterns that would otherwise remain undocumented.

A third driver is the expansion of ambulatory and home-based neurological care. U.S. providers face pressure to manage more patients without proportionally expanding specialist staffing. Wearable devices can extend observation beyond the hospital or clinic and allow selected patients to be monitored remotely. The model is particularly relevant for epilepsy follow-up, medication titration, movement-disorder management, post-stroke rehabilitation, fall-risk assessment, and chronic pain or migraine treatment.

CMS remote physiological monitoring and remote therapeutic monitoring frameworks have also increased provider familiarity with connected-device workflows. Reimbursement is not automatic for every neurological wearable, and eligibility depends on the device, data, service, documentation, and payer requirements. Nevertheless, the existence of remote-monitoring payment infrastructure improves the commercial environment for platforms that can produce medically relevant data and support documented clinical management.

A fourth driver is growing demand for drug-free and non-invasive treatment options. Migraine, tremor, neuropathic pain, depression, attention disorders, and other neurological or neurobehavioral conditions are being addressed through wearable electrical stimulation technologies. These devices are attractive to patients who experience medication side effects, incomplete symptom control, contraindications, adherence challenges, or a preference for non-pharmacological care.

Prescription wearable neuromodulation has progressed beyond basic transcutaneous electrical stimulation. Newer platforms use condition-specific waveforms, remote electrical neuromodulation, external trigeminal nerve stimulation, transcutaneous afferent patterned stimulation, non-invasive vagus nerve stimulation, and transcranial electrical stimulation. The commercial value lies in delivering a repeatable therapy while simultaneously generating adherence and treatment-response information.

A fifth driver is rapid growth in epilepsy safety and seizure-monitoring applications. Seizures that occur at night or without a caregiver present a major source of anxiety and clinical uncertainty. Wrist-worn and arm-worn systems can combine motion, electrodermal activity, heart rate, or other signals to identify patterns associated with major motor seizures and alert designated caregivers. Extended-wear scalp sensors and ambulatory EEG technologies are also increasing the duration over which brain activity can be recorded outside a conventional epilepsy-monitoring unit.

The epilepsy segment benefits from a clear unmet need, measurable clinical events, and strong caregiver involvement. However, commercial success depends on managing false alarms, clearly communicating that adjunctive monitoring does not replace clinical supervision, and setting realistic expectations regarding which seizure types can be detected.

A sixth driver is the need for objective digital biomarkers in Parkinson’s disease and other movement disorders. Conventional rating scales remain important, but they are influenced by examination timing and observer variability. Wearable inertial sensors can quantify tremor, bradykinesia, dyskinesia, gait speed, step variability, turning, balance, and activity patterns. Continuous or repeated measurement can help clinicians understand whether treatment changes improve the patient’s daily function rather than only the examination-room score.

The use of wearable movement data is also expanding in pharmaceutical development. Sponsors can use digital endpoints to measure treatment response more frequently than traditional site visits permit. This creates demand from pharmaceutical companies, contract research organizations, and academic research networks in addition to direct clinical demand.

A seventh driver is the growth of decentralized and hybrid clinical trials. Neurological trials frequently face long timelines, high site costs, variable patient performance, and difficulty measuring progression. Wearables can collect functional data between visits, reduce dependence on patient diaries, and provide higher-frequency endpoints. Parkinson’s disease, multiple sclerosis, epilepsy, dementia, stroke rehabilitation, sleep disorders, and neuromuscular diseases are particularly relevant areas.

Research adoption can accelerate clinical commercialization because trial use produces validation data, clinician familiarity, and pharmaceutical partnerships. Devices that establish themselves as reliable research instruments may later enter care-management workflows, although regulatory claims for research and clinical use remain distinct.

An eighth driver is demographic aging. Neurological disease prevalence rises substantially with age, while older adults frequently experience multiple interacting risks such as cognitive impairment, gait instability, medication complexity, sleep disturbance, and falls. Wearables can support monitoring without requiring frequent travel to specialist centers. The technology is especially relevant in states with large older populations, including Florida, Maine, Pennsylvania, West Virginia, Arizona, and portions of the Midwest.

A ninth driver is specialist scarcity and geographic access inequality. Many U.S. patients live far from comprehensive epilepsy centers, movement-disorder specialists, dementia clinics, or neurorehabilitation programs. A wearable device does not replace a neurologist, but it can improve the quality of information available during remote consultations and help specialists prioritize patients who require in-person evaluation.

A tenth driver is hospital procurement pressure to demonstrate measurable economic value. Hospitals are experiencing rising labor, supply, and infrastructure costs. Neurological wearable platforms must therefore show that they can reduce inpatient observation time, avoid unnecessary admissions, shorten diagnostic pathways, improve therapist productivity, or support discharge to a lower-cost setting. Devices that merely add another dashboard without reducing clinical workload are likely to face resistance.

The strongest market growth will come from products that create a direct link between sensor output and a clinical or economic action. Examples include alerting a caregiver to a major seizure, documenting medication-related motor fluctuation, confirming rehabilitation adherence, identifying deteriorating gait, reducing migraine medication dependence, or extending EEG observation without requiring prolonged inpatient admission.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. wearable neurology devices market is increasingly centered on signal quality, clinical specificity, patient comfort, and interpretation efficiency. The competitive standard is no longer defined by whether a sensor can collect data. It is defined by whether the system can collect usable data over a meaningful duration, distinguish clinically relevant events from ordinary activity, and deliver information in a form that supports medical decisions.

Wearable EEG is one of the most strategically important innovation areas. Conventional EEG remains essential, but standard recordings may be too short to capture intermittent abnormalities. Newer reduced-montage headsets, adhesive scalp sensors, dry-electrode systems, and wireless ambulatory platforms are designed to extend recording duration while reducing setup complexity. Some systems can transmit data to secure cloud environments for remote review, improving access where continuous on-site neurodiagnostic staffing is limited.

Extended wear creates its own engineering requirements. Electrodes must maintain signal quality, adhesives must minimize skin injury, batteries must support prolonged recording, and the device must remain comfortable during sleep and normal activity. Manufacturers that solve these practical constraints can address a significant gap between routine outpatient EEG and resource-intensive inpatient monitoring.

Multimodal seizure detection is another major innovation area. Motion alone can produce false alarms because many ordinary activities resemble convulsive movement. Combining accelerometry with electrodermal activity, heart rate, temperature, muscle activity, or sleep-state information can improve event classification. The commercial objective is not simply higher theoretical sensitivity; it is a clinically acceptable balance between sensitivity and alert burden.

Movement-disorder technologies are progressing from passive measurement to individualized treatment. Wrist-worn devices can quantify tremor frequency and deliver patterned peripheral nerve stimulation calibrated to the user. Other systems measure bradykinesia, dyskinesia, gait, and activity to help clinicians understand motor fluctuation. The next generation is expected to combine measurement and intervention, allowing therapy intensity or timing to be adjusted according to detected symptoms.

Migraine wearables are also developing into integrated treatment platforms. App-controlled systems can deliver non-invasive neuromodulation, record symptoms, track treatment timing, and help patients identify patterns. Pediatric indications, preventive use, and dual acute-preventive positioning are broadening the potential patient base. These products compete not only with other devices but also with prescription drugs, over-the-counter medications, injectable therapies, and behavioral interventions.

Neurorehabilitation innovation is focused on increasing therapy intensity outside supervised sessions. Wearable motion sensors, instrumented gloves, exosleeves, smart orthoses, balance systems, and biofeedback platforms can measure repetition, range of motion, upper-limb use, gait symmetry, and adherence. These technologies address a persistent economic problem: patients need frequent practice, but therapist time is limited and expensive.

Artificial intelligence is becoming a horizontal technology layer across the market. Algorithms are used to identify seizure-associated patterns, separate tremor from voluntary movement, classify gait abnormalities, summarize EEG, estimate sleep states, detect functional decline, and prioritize records for review. AI can reduce clinician workload, but algorithm performance must be demonstrated across different ages, skin characteristics, disease severities, movement patterns, and real-world use conditions.

Digital biomarker development is another priority. A conventional wearable metric such as step count has limited neurological specificity. Higher-value platforms derive condition-relevant measures such as percentage of time with dyskinesia, tremor severity during functional tasks, freezing-of-gait frequency, nocturnal movement patterns, limb-use asymmetry, seizure-event probability, or change in cognitive-motor interaction. These biomarkers are more useful for treatment decisions and clinical trials.

Patient adherence is also becoming an innovation domain. Devices are being designed to reduce charging frequency, simplify placement, minimize visible medicalization, and provide immediate feedback. Adhesive wearables, discreet wrist devices, lightweight headsets, and smartphone-connected therapies are more likely to be used consistently than products requiring complicated daily setup.

Data integration will increasingly differentiate manufacturers. Neurologists do not need unrestricted raw data from every patient. They need trend summaries, event verification, treatment-response comparisons, and clear escalation criteria. Companies that integrate wearable information into electronic health records, research platforms, or specialty dashboards will be better positioned than companies that require clinicians to manage a separate and poorly connected data environment.

Regulatory strategy is becoming equally important. Wearable companies must determine whether their products are wellness devices, physiological monitors, diagnostic aids, therapeutic devices, or software-enabled medical systems. Each positioning choice affects evidence requirements, labeling, commercial claims, software controls, cybersecurity responsibilities, and post-market surveillance. Manufacturers with disciplined regulatory and evidence-generation programs will have an advantage as the market matures.

 

Segmentation Insights

The U.S. Wearable Neurology Devices Market is segmented on the basis of product category, application, technology type, end user, and region.

 

By Product Category

Wearable EEG and Neural Monitoring Systems

Wearable EEG and neural monitoring systems represented an estimated USD 0.91 billion in 2025, making them one of the largest product categories. The segment includes ambulatory EEG headsets, adhesive scalp sensors, reduced-montage systems, portable rapid EEG devices, dry-electrode headsets, and cloud-connected neural signal platforms.

Demand is supported by epilepsy evaluation, altered mental-status assessment, sleep-related neurological monitoring, critical-care neurology, traumatic brain injury assessment, and clinical research. Extended-duration systems are commercially attractive because they can capture events that may not occur during a conventional short EEG recording. Growth will depend on electrode durability, signal quality, ease of application, data-review efficiency, and payer acceptance.

Seizure Detection and Caregiver-Alert Wearables

The seizure detection and alert category was valued at approximately USD 0.63 billion in 2025. These devices are commonly worn on the wrist or upper arm and use accelerometry, electrodermal activity, photoplethysmography, heart rate, temperature, or multimodal algorithms to identify patterns associated with selected seizure types.

The strongest use case is monitoring major motor seizures during sleep or periods of rest. Pediatric epilepsy and caregiver-supported home monitoring are important submarkets. The category is expected to expand as device indications broaden, but manufacturers must clearly distinguish seizure detection from seizure prediction and diagnosis.

Movement, Gait, Tremor and Balance Wearables

Movement and gait wearables generated an estimated USD 0.52 billion in 2025. This category includes wrist sensors, ankle sensors, instrumented insoles, inertial measurement units, gait belts, tremor monitors, balance sensors, and wearable systems designed to quantify Parkinsonian motor symptoms.

Clinical value comes from measuring fluctuations that are difficult to capture during periodic consultations. The segment also has strong pharmaceutical research potential because objective movement data can support treatment-response analysis. Products that deliver interpretable reports rather than large volumes of raw motion data will achieve stronger adoption.

Wearable Therapeutic Neuromodulation Devices

Wearable therapeutic neuromodulation devices represented approximately USD 0.72 billion in 2025. The category includes migraine-treatment wearables, tremor-relief wrist devices, external trigeminal nerve stimulators, remote electrical neuromodulation systems, non-invasive vagus nerve stimulators, transcranial stimulation headsets, and wearable pain-management technologies.

This segment is expected to record one of the highest growth rates through 2035. Demand is supported by patient interest in non-pharmacological therapy, expanding indications, app-based treatment management, and the potential for repeated home use. Coverage variability and out-of-pocket affordability remain important commercial considerations.

Neurorehabilitation, Cognitive and Sleep-Related Wearables

Neurorehabilitation, cognitive, and sleep-related devices accounted for an estimated USD 0.40 billion in 2025. Products include smart rehabilitation gloves, upper-limb activity monitors, wearable gait-training systems, neurofeedback headsets, cognitive-assessment wearables, sleep EEG devices, and systems that measure neurological recovery after stroke or brain injury.

Growth is supported by the movement of rehabilitation into the home and the need to document patient activity between therapy visits. The category is fragmented, with products ranging from regulated medical devices to research and wellness technologies. Clinically validated platforms with strong therapist workflows are expected to gain share.

 

By Application

Epilepsy and Seizure Management

Epilepsy and seizure management was the largest application segment, with an estimated value of USD 0.78 billion in 2025. Wearable devices are used for ambulatory EEG acquisition, major motor seizure detection, caregiver notification, event documentation, sleep monitoring, and long-term physiological data collection.

The addressable patient population includes approximately 3 million U.S. adults with active epilepsy and a substantial pediatric population. Commercial demand is strongest among patients with poorly controlled seizures, nocturnal events, developmental disabilities, or high caregiver concern. Future growth will depend on broader seizure-type detection, improved specificity, pediatric evidence, and integration with epilepsy-care workflows.

Parkinson’s Disease, Essential Tremor and Other Movement Disorders

Movement-disorder applications represented approximately USD 0.62 billion in 2025. The segment includes monitoring and therapeutic devices used for Parkinson’s disease, essential tremor, dystonia, ataxia, and other disorders affecting movement or coordination.

More than 1 million Americans are living with Parkinson’s disease, and approximately 90,000 new cases are diagnosed each year. Wearables can quantify tremor, gait, bradykinesia, dyskinesia, turning, posture, medication-response cycles, and functional activity. Wrist-worn stimulation devices also provide a non-invasive therapeutic option for selected tremor symptoms.

Migraine, Headache and Neuropathic Pain

Migraine, headache, and neurological pain applications generated approximately USD 0.73 billion in 2025. The category includes wearable remote electrical neuromodulation devices, trigeminal nerve stimulation systems, non-invasive vagus nerve stimulation, and connected pain-management wearables.

The large U.S. migraine population creates a broad commercial opportunity. Device adoption is strongest among patients who experience medication side effects, medication-overuse concerns, contraindications, or insufficient response to pharmacological therapy. Expansion into preventive use and younger age groups can materially increase the addressable market.

Stroke, Traumatic Brain Injury and Neurorehabilitation

Stroke, TBI, and neurorehabilitation applications represented approximately USD 0.58 billion in 2025. Wearables are used to track gait, upper-limb movement, balance, therapy repetition, muscle activation, cognitive-motor performance, and community mobility.

The United States recorded approximately 214,000 TBI-related hospitalizations in the latest broadly reported national hospitalization dataset and more than 68,000 TBI-related deaths in 2023. Stroke and brain injury survivors often require prolonged rehabilitation, creating demand for systems that increase therapy intensity and document functional recovery after discharge.

Dementia, Cognitive Monitoring, Sleep and Neurobehavioral Applications

Dementia, cognitive, sleep, and neurobehavioral applications were valued at approximately USD 0.47 billion in 2025. The segment includes sleep EEG systems, cognitive monitoring platforms, activity and wandering sensors, neurofeedback headsets, attention-related stimulation devices, and wearables used to identify changes in sleep, mobility, or daily behavior.

An estimated 7.2 million Americans aged 65 and older had Alzheimer’s dementia in 2025. Wearables are not replacements for comprehensive cognitive evaluation, but longitudinal activity, sleep, gait, and behavioral data may support earlier identification of functional change and improve caregiver oversight.

 

By Technology Type

EEG and Electrophysiological Signal Technologies

EEG and related electrophysiological technologies accounted for approximately USD 0.88 billion in 2025. The category includes wet and dry electrodes, reduced-montage headsets, adhesive sensors, ambulatory EEG systems, and wearable neurophysiology platforms.

Signal integrity is the central competitive factor. Devices must reduce motion artifacts, maintain stable electrode contact, and support reliable recording during sleep and daily activity. Products that automate data preparation and review can reduce the operational burden placed on neurologists and EEG technologists.

Inertial, Motion and Pressure-Sensing Technologies

Inertial and motion-sensing technologies represented approximately USD 0.59 billion in 2025. Accelerometers, gyroscopes, magnetometers, pressure sensors, and instrumented textiles are used to measure tremor, gait, posture, falls, limb use, and rehabilitation activity.

These components are widely available, making algorithms, clinical validation, and workflow design more important than the sensors themselves. Condition-specific interpretation differentiates medical-grade neurological platforms from general-purpose activity trackers.

Multimodal Physiological Sensor Platforms

Multimodal sensor platforms were valued at approximately USD 0.62 billion in 2025. These systems combine motion data with electrodermal activity, heart rate, skin temperature, muscle activity, oxygen saturation, sleep data, or other physiological signals.

Multimodal sensing is particularly important in seizure monitoring because combining signals can improve event classification. It is also relevant in autonomic dysfunction, sleep disorders, fatigue measurement, pain assessment, and neurodegenerative disease monitoring.

Non-Invasive Electrical Stimulation Technologies

Non-invasive stimulation technologies generated approximately USD 0.76 billion in 2025, making them the largest individual technology category by value. These devices use peripheral nerve stimulation, trigeminal stimulation, vagus nerve stimulation, transcranial stimulation, or remote electrical neuromodulation.

The technology supports home-based treatment and recurring device utilization. Manufacturers are focusing on individualized waveforms, app-guided therapy, adherence tracking, reusable hardware, and disposable treatment components. Strong clinical evidence and indication-specific regulatory clearance are essential for premium adoption.

AI, Cloud Analytics and Digital Biomarker Platforms

Platforms classified primarily around AI, cloud analytics, and digital biomarkers represented approximately USD 0.33 billion in 2025. Their direct revenue contribution remains smaller than hardware-led categories, but their strategic influence is substantially larger.

These platforms classify events, summarize long-duration data, generate neurological scores, support remote review, and connect wearable information with clinical or research systems. Subscription revenue and pharmaceutical research contracts are expected to make this the fastest-growing technology segment through 2035.

 

By End User

Hospitals and Academic Medical Centers

Hospitals and academic medical centers accounted for approximately USD 1.03 billion in 2025. These institutions purchase wearable EEG systems, seizure-monitoring platforms, rapid neurological assessment technologies, research wearables, and rehabilitation devices.

Academic centers are especially important because they conduct validation studies, influence specialist opinion, train clinicians, and serve complex patients. Procurement decisions typically require evidence of clinical utility, technical support, cybersecurity readiness, and integration with hospital information systems.

Neurology Clinics and Specialty Care Centers

Neurology clinics, epilepsy centers, headache clinics, sleep centers, and movement-disorder practices generated approximately USD 0.75 billion in 2025. These providers are central to prescription-based wearable adoption and longitudinal data interpretation.

Specialty practices prioritize platforms that simplify patient setup, generate concise reports, and support treatment adjustment. Reimbursement guidance, patient onboarding, and technical support can materially influence vendor selection.

Home Healthcare, Patients and Caregivers

Home-based users represented approximately USD 0.68 billion in 2025. This category includes prescribed seizure-alert wearables, migraine-treatment devices, tremor systems, sleep-monitoring devices, and rehabilitation wearables used outside a formal care facility.

The home segment is expected to gain share as devices become easier to use and as neurological care moves toward longitudinal monitoring. Adoption depends on comfort, battery performance, smartphone compatibility, caregiver engagement, affordability, and clarity regarding how alerts or data should be acted upon.

Rehabilitation Hospitals and Therapy Providers

Rehabilitation hospitals, outpatient therapy centers, skilled nursing facilities, and home-therapy providers accounted for approximately USD 0.42 billion in 2025. Wearables are used to measure gait, balance, range of motion, limb activity, exercise repetition, and adherence.

Purchasing decisions are closely linked to therapist productivity and measurable functional improvement. Platforms that allow one clinician to supervise more patients or identify non-adherence between visits can create a stronger economic case.

Pharmaceutical Companies, CROs and Research Institutions

Pharmaceutical companies, contract research organizations, universities, and government-supported research programs generated approximately USD 0.30 billion in 2025. These users deploy wearables to collect digital endpoints, identify treatment response, monitor safety, and support decentralized trials.

The segment can produce high-value contracts and accelerate device validation. However, research-grade data requirements are demanding, particularly around calibration, protocol consistency, missing data, device changes, and longitudinal comparability.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Wearable Neurology Devices Market is geographically segmented into the Northeast, Midwest, South, and West. Regional performance differs according to population size, age profile, neurological disease burden, academic-center concentration, digital-health adoption, specialist access, research activity, payer mix, and the maturity of home-based care.

The South was the largest regional market in 2025, while the West is expected to record the fastest CAGR through 2035. The Northeast remains the most academically intensive and evidence-driven market. The Midwest provides a stable base of hospital, rehabilitation, medtech, and movement-disorder demand.

South

The South represented an estimated USD 1.08 billion in 2025 and is projected to reach approximately USD 4.56 billion by 2035. The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. The District of Columbia also forms an important specialized healthcare market within the broader regional ecosystem.

The South’s leadership is supported by its large population, rapid growth in several metropolitan areas, substantial rural population, high stroke and chronic disease burden, and expanding base of older adults. From 2020 to 2025, the South recorded stronger growth across age groups than the other major U.S. regions, increasing the long-term patient pool for neurological diagnosis, rehabilitation, and home monitoring.

Texas is the largest state-level opportunity in the region. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major academic hospitals, integrated health systems, children’s hospitals, veterans’ healthcare facilities, and neurological research programs. The state’s geographic scale also creates a strong use case for remote seizure monitoring, home rehabilitation, and specialist-supported wearable programs.

Florida is a major market for Parkinson’s disease, dementia, stroke rehabilitation, fall-risk monitoring, sleep-related neurological assessment, and caregiver-connected wearables because of its large older population. Miami, Tampa, Orlando, Jacksonville, and South Florida contain significant hospital and specialty-care capacity. Home-use devices are particularly relevant because many patients require longitudinal monitoring across multiple care settings.

North Carolina has a strong academic and research base centered around the Research Triangle, Charlotte, Winston-Salem, and other clinical hubs. The state is attractive for pharmaceutical collaborations, digital biomarker research, neurorehabilitation, and clinical trials. Georgia similarly benefits from Atlanta’s large health systems, academic providers, pediatric networks, and technology ecosystem.

Virginia and Maryland are important markets due to their proximity to federal agencies, military and veterans’ healthcare systems, biomedical research organizations, and major academic centers. Wearable technologies for traumatic brain injury, rehabilitation, sleep, migraine, and neurological performance have particular relevance within defense and veteran populations.

Tennessee has established academic and regional referral centers in Nashville, Memphis, and Knoxville. Its market opportunity spans pediatric epilepsy, stroke care, rehabilitation, and movement disorders. Kentucky, West Virginia, Mississippi, Alabama, Arkansas, and Louisiana have significant neurological and vascular disease burdens but more uneven specialist access. These states are attractive for scalable monitoring solutions that connect community providers with regional centers.

Oklahoma and South Carolina are expected to experience steady growth as health systems expand tele-neurology, outpatient rehabilitation, and home-based chronic disease programs. Delaware is a smaller market but benefits from proximity to major Northeast and Mid-Atlantic healthcare networks.

The South presents both premium and access-driven opportunities. Advanced academic centers can adopt high-value EEG, AI, and research platforms, while rural and community markets require simpler devices with strong remote support. Vendors must therefore adapt pricing, training, connectivity, and service models across highly different care environments.

West

The West represented approximately USD 0.78 billion in 2025 and is projected to reach nearly USD 3.65 billion by 2035, making it the fastest-growing region. The West includes California, Washington, Oregon, Nevada, Arizona, New Mexico, Colorado, Utah, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the dominant state market. It combines a large patient population, internationally recognized academic medical centers, digital-health companies, venture capital, medical-device developers, pharmaceutical research, and sophisticated integrated delivery networks. The state is particularly important for wearable EEG, AI-enabled neurological monitoring, migraine neuromodulation, tremor technology, decentralized trials, and digital biomarker platforms.

The San Francisco Bay Area and Southern California contain a high concentration of neurotechnology developers, software companies, clinical researchers, and early-stage investors. California providers are frequently early evaluators of novel connected devices, although procurement standards are rigorous and cybersecurity, interoperability, and clinical evidence requirements are substantial.

Washington and Oregon have strong integrated health systems and comparatively advanced connected-care infrastructure. Seattle is an important research and technology center, while Portland supports neurological specialty care and digital-health adoption. These states are attractive for enterprise deployments that combine clinical monitoring, patient engagement, and population-health management.

Arizona and Nevada are high-growth markets because of population expansion, inward migration, and aging demographics. Phoenix, Tucson, Las Vegas, and Reno are expanding neurological and rehabilitation capacity. Parkinson’s monitoring, dementia-support technologies, fall prevention, stroke rehabilitation, and home-use neurological devices are particularly relevant.

Colorado and Utah combine growing populations with established research, medtech, and integrated-care ecosystems. Salt Lake City has become an important center for wearable EEG and neurological device innovation. Colorado’s academic centers and health systems support movement-disorder research, TBI programs, rehabilitation, and digital trial activity.

New Mexico, Idaho, Montana, and Wyoming have lower absolute market values but substantial geographic access challenges. Remote data collection can reduce the need for repeated long-distance travel, although connectivity, specialist availability, and payer economics remain barriers. Alaska and Hawaii face even more distinctive logistical conditions, increasing the potential value of reliable remote neurological assessment.

The West’s growth will be driven by the interaction between device development and clinical adoption. Many companies in the region can test products through nearby academic and integrated health systems, refine their digital infrastructure, and build pharmaceutical partnerships. This innovation density gives the West an advantage in AI-enabled monitoring and software-linked neurology.

Northeast

The Northeast accounted for approximately USD 0.72 billion in 2025 and is projected to reach nearly USD 2.85 billion by 2035. The region includes Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, and Pennsylvania.

The Northeast has the country’s highest concentration of influential academic hospitals, neurological specialists, clinical trial centers, and biomedical research institutions. Massachusetts, New York, and Pennsylvania are particularly important for wearable EEG, epilepsy research, movement-disorder programs, neurodegenerative disease trials, and advanced rehabilitation.

New York is the region’s largest state market because of its population, health-system scale, specialist density, and major academic centers. New York City supports premium adoption, complex epilepsy care, research programs, and technology evaluation. Upstate New York creates a different opportunity centered on extending specialist services across geographically dispersed communities.

Massachusetts has a smaller population but disproportionate strategic influence. Boston-area institutions frequently participate in early-stage validation, pharmaceutical partnerships, digital biomarker development, and neurological clinical trials. Manufacturers seeking national credibility often prioritize relationships with these institutions.

Pennsylvania provides a large and diversified market across Philadelphia, Pittsburgh, central Pennsylvania, and rural areas. The state has a comparatively older population and strong demand for dementia care, Parkinson’s disease management, stroke rehabilitation, and hospital-based neurodiagnostics.

New Jersey benefits from its pharmaceutical industry, contract research activity, and proximity to New York and Philadelphia. The state is particularly relevant for research-use wearables and decentralized clinical trials. Connecticut and Rhode Island provide concentrated academic and specialty-care markets.

Maine, Vermont, and New Hampshire have smaller populations but older demographic profiles and rural access challenges. Home-based monitoring, fall-risk assessment, cognitive support, and remote neurological care are important opportunities. Vendors operating in these states require reliable logistics and low-burden patient setup.

Northeast procurement is highly evidence-driven. Clinical leaders and value-analysis committees frequently expect peer-reviewed validation, workflow documentation, data-security review, and a credible economic case. Market growth may be slower than in the West, but average value per deployment can be higher because of the region’s concentration of advanced programs and clinical research.

Midwest

The Midwest represented an estimated USD 0.60 billion in 2025 and is projected to reach approximately USD 2.25 billion by 2035. The region includes Ohio, Indiana, Illinois, Michigan, Wisconsin, Minnesota, Iowa, Kansas, Missouri, Nebraska, North Dakota, and South Dakota.

Illinois, Ohio, Michigan, and Minnesota are the largest state opportunities. Chicago supports a broad ecosystem of academic hospitals, community health systems, rehabilitation providers, and neurological specialty programs. Ohio has major neurological centers and a strong base of hospital-led innovation. Michigan combines significant stroke, movement-disorder, and rehabilitation demand with a large health-system network.

Minnesota is strategically important because of its medtech heritage, neurological expertise, and established medical-device workforce. The state is well positioned for development and commercialization of wearable stimulation, monitoring, and rehabilitation systems.

Indiana and Wisconsin provide stable demand across hospitals, neurology clinics, and rehabilitation networks. Missouri has important academic and regional referral centers in St. Louis and Kansas City. Iowa, Kansas, and Nebraska offer opportunities for remote monitoring that connects rural patients with tertiary-care centers.

North Dakota and South Dakota are smaller markets, but long travel distances and limited specialist density strengthen the clinical rationale for remote neurological data collection. Products must be supported by straightforward workflows because smaller facilities may lack dedicated digital-health implementation teams.

The Midwest is expected to grow more steadily than the West or South. Manufacturers can succeed through service reliability, clinical education, practical integration, and health-system contracting. The region is particularly attractive for movement-disorder monitoring, rehabilitation wearables, ambulatory EEG, and research partnerships with established medical centers.

 

Key Market Players

The U.S. Wearable Neurology Devices Competitive Landscape is fragmented but becoming more structured as regulatory-grade platforms separate from general wellness wearables. Competition includes dedicated neurotechnology companies, established neurodiagnostic suppliers, wearable-sensor manufacturers, neuromodulation specialists, and digital biomarker developers.

Some of the key players in the U.S. Wearable Neurology Devices industry are Empatica, Epitel, LivAssured, Ceribell, BrainScope, Cala Health, Theranica, CEFALY Technology, Neurolief, electroCore, NeuroMetrix, NeuroSigma, Great Lakes NeuroTechnologies, Global Kinetics Corporation, Rune Labs, Zeto, Natus Medical, Compumedics, Advanced Brain Monitoring, BioSerenity, EMOTIV, InteraXon, Neuroelectrics, Soterix Medical, and Flow Neuroscience.

Empatica, Epitel, and LivAssured are important participants in seizure detection and ambulatory neurological monitoring. Ceribell, Zeto, Natus Medical, Compumedics, BioSerenity, and Advanced Brain Monitoring compete across EEG acquisition, rapid assessment, ambulatory recording, and neurodiagnostic workflows.

Cala Health has established a differentiated position in wearable tremor treatment through personalized wrist-based stimulation. Theranica, CEFALY Technology, Neurolief, and electroCore compete in non-invasive migraine and headache therapy using different stimulation targets and treatment approaches.

Great Lakes NeuroTechnologies, Global Kinetics Corporation, and Rune Labs are associated with movement-disorder measurement and digital neurological data. BrainScope addresses portable neurological assessment, while NeuroSigma, Neuroelectrics, Soterix Medical, and Flow Neuroscience participate in external stimulation and neurobehavioral applications.

EMOTIV and InteraXon are influential in wearable EEG and neurofeedback, with commercial positions spanning research, wellness, and selected professional applications. Their inclusion illustrates an important competitive boundary: the market contains regulated medical systems alongside research and consumer-oriented technologies, but their clinical claims and commercialization pathways differ significantly.

Competition will increasingly center on indication-specific evidence rather than sensor specifications. Manufacturers must demonstrate that the device works in the intended patient population, over the intended wear period, and under real-world conditions. Clinical utility, not only technical accuracy, will determine hospital and payer acceptance.

Business-model competition is also intensifying. Some companies sell reusable hardware with subscription software. Others rely on disposable sensors, per-treatment devices, or research contracts. Vendors offering low initial hardware costs may generate higher recurring revenue through consumables and data services.

Market share through 2035 will be influenced by FDA clearance, software reliability, cybersecurity, reimbursement support, patient adherence, clinician training, and the ability to build distribution across specialty practices. Pharmaceutical partnerships and clinical-trial use will also become important because they provide revenue, validation, and access to large neurological datasets.

Consolidation is likely as larger medical-device, diagnostics, pharmaceutical-services, and digital-health companies seek access to validated neurological data. Potential acquisition targets will include companies with proprietary datasets, condition-specific algorithms, recurring revenue, FDA-cleared platforms, and established relationships with academic neurological centers.

 

Recent Developments

Recent developments in the U.S. Wearable Neurology Devices Market demonstrate a clear shift toward longer-duration neurological monitoring, pediatric home use, multimodal seizure detection, and personalized wearable therapy.

In 2025, the FDA cleared an updated EpiMonitor system developed by Empatica. The prescription system combines a wrist-worn device with mobile and cloud software and is intended as an adjunct to seizure monitoring in adults and children aged six and older. The system uses electrodermal activity and motion data to identify patterns that may be associated with selected generalized tonic-clonic seizures and can initiate caregiver alerts through a paired mobile device.

Epitel also received FDA clearance in 2025 for an updated REMI Remote EEG Monitoring System. The platform uses disposable wearable scalp sensors to capture and wirelessly transmit EEG data in healthcare and ambulatory settings. The updated indication covers adult and pediatric patients aged one year and older and supports recording for up to 30 days. This development illustrates the movement toward longer-duration EEG acquisition outside traditional inpatient monitoring environments.

LivAssured received U.S. clearance for NightWatch+ in 2025. The prescription system is intended as an adjunct to nocturnal seizure monitoring for children aged four to 16 with defined major motor seizure types. An upper-arm sensor measures heart rate and motion and sends alerts to a caregiver alarm station when an event pattern is detected.

Cala Health received FDA clearance in January 2025 for an updated Cala kIQ prescription device. The lightweight wrist-worn system uses onboard motion sensors to identify the user’s tremor frequency and applies transcutaneous afferent patterned stimulation through the median and radial nerves. The device is indicated for temporary relief of hand tremor in adults with essential tremor and selected postural and kinetic tremor symptoms associated with Parkinson’s disease.

Wearable migraine therapy also continued to expand. Prescription devices increasingly support both acute and preventive treatment, broader pediatric indications, app-controlled stimulation, and symptom tracking. This is moving migraine wearables from occasional rescue products toward longitudinal disease-management platforms.

FDA attention to sensor-based digital health technologies and AI-enabled medical devices is increasing regulatory visibility for wearable systems. Manufacturers are placing greater emphasis on software documentation, algorithm-change management, human factors, cybersecurity, and post-market data rather than treating the wearable as a hardware-only product.

Pharmaceutical companies are expanding their use of wearable neurological endpoints in decentralized and hybrid trials. Movement, sleep, gait, cognition, tremor, and seizure-related data are being evaluated as complementary endpoints that can increase measurement frequency and reduce dependence on patient recall.

Hospitals are also becoming more selective. Pilot programs are increasingly expected to define a target population, clinical owner, review workflow, escalation process, and economic objective before broad deployment. This favors companies with implementation teams and specialty-care expertise over technology vendors that provide devices without workflow support.

 

Conclusion

The U.S. Wearable Neurology Devices Market Size & Share is positioned for rapid expansion from approximately USD 3.18 billion in 2025 to USD 13.31 billion by 2035, supported by a 15.39% CAGR during the 2026–2035 forecast period. The historical market expanded from USD 1.78 billion in 2021 to USD 2.72 billion in 2024 as neurological monitoring moved beyond fixed clinical environments.

The market’s long-term strength is supported by the high burden of epilepsy, Parkinson’s disease, migraine, stroke disability, traumatic brain injury, dementia, and sleep-related neurological conditions. These diseases require longitudinal information that conventional episodic examinations cannot consistently provide.

The most attractive opportunities will emerge in extended-wear EEG, multimodal seizure detection, personalized tremor therapy, migraine neuromodulation, movement-disorder digital biomarkers, home neurorehabilitation, and AI-assisted data interpretation. Software, cloud services, disposable sensors, and research contracts will become increasingly important revenue sources.

The South will remain the largest regional market because of its population scale, older-adult growth, disease burden, and specialist-access gaps. The West will grow fastest because of its concentration of neurotechnology companies, venture investment, digital-health infrastructure, and early-adopting health systems. The Northeast will remain central to clinical validation and premium adoption, while the Midwest will provide stable demand supported by established medical centers, medtech expertise, and regional referral networks.

For hospital buyers, the decisive question will not be how much data a wearable can generate. It will be whether the device improves a defined clinical workflow without creating unsustainable review burden. Products that reduce diagnostic uncertainty, support treatment adjustment, increase rehabilitation intensity, or prevent avoidable utilization will receive stronger procurement consideration.

For manufacturers, regulatory clearance alone will not guarantee commercial adoption. Companies must demonstrate patient adherence, algorithm reliability, integration readiness, cybersecurity, economic value, and measurable clinical utility. They must also distinguish medical-grade capabilities from general consumer-wearable functionality.

For pharmaceutical and research clients, wearable neurology platforms offer an opportunity to develop higher-frequency digital endpoints and understand treatment response in real-world settings. Devices with validated measures, stable longitudinal performance, and regulatory-grade data governance will be best positioned for clinical-trial partnerships.

The central competitive shift through 2035 will be from stand-alone devices toward integrated neurological management platforms. Companies capable of combining sensing, therapy, interpretation, clinician workflow, patient engagement, and real-world evidence will define the next phase of the U.S. wearable neurology devices industry.

 

TABLE OF CONTENT

1. U.S. Wearable Neurology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Devices and Solutions Included in the Market Scope
1.2.2. Devices and Solutions Excluded from the Market Scope
1.2.3. U.S. Market Coverage
1.2.4. Historical Period, 2021–2024
1.2.5. Base Year, 2025
1.2.6. Forecast Period, 2026–2035
1.2.7. Market Value Measurement in US$ Billion
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up Market Sizing
1.3.6. Top-Down Market Validation
1.3.7. Demand-Side and Supply-Side Triangulation
1.3.8. Analytical Frameworks & Forecasting Models
1.3.9. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Wearable Neurology Device Manufacturers
1.6.2. EEG Electrode, Biosensor and Component Suppliers
1.6.3. Semiconductor, Battery and Connectivity Providers
1.6.4. Software, Cloud Analytics and AI Algorithm Developers
1.6.5. Contract Development and Manufacturing Organizations
1.6.6. Hospitals and Integrated Delivery Networks
1.6.7. Academic Medical Centers and Neurology Research Institutions
1.6.8. Epilepsy, Movement Disorder, Headache and Sleep Clinics
1.6.9. Rehabilitation Hospitals and Therapy Providers
1.6.10. Home Healthcare Providers, Patients and Caregivers
1.6.11. Pharmaceutical Companies and Contract Research Organizations
1.6.12. Distributors, Specialty Suppliers and Digital Health Channels
1.6.13. Commercial Payers, Medicare and Medicaid Stakeholders
1.6.14. FDA, Clinical Decision-Makers and Patient Advocacy Organizations

What this section provides: This section defines the market boundary, study scope, methodology, assumptions, exclusions, and stakeholder ecosystem so clients understand how the U.S. wearable neurology devices market is measured, segmented, and validated.

2. U.S. Wearable Neurology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025–2035
2.8. CAGR Analysis, 2026–2035
2.9. Fastest-Growing Product Categories
2.10. Fastest-Growing Clinical Applications
2.11. Leading Technology Platforms
2.12. High-Growth End-User Groups
2.13. Regional and State-Level Opportunity Summary
2.14. High-Growth Opportunity Areas
2.14.1. Extended-Wear Ambulatory EEG
2.14.2. Multimodal Seizure Detection
2.14.3. Wearable Tremor Therapy
2.14.4. Migraine Neuromodulation
2.14.5. Parkinson’s Disease Digital Biomarkers
2.14.6. Home-Based Neurorehabilitation
2.14.7. Decentralized Neurology Clinical Trials
2.14.8. AI-Assisted Neurological Data Interpretation

What this section provides: This section gives decision-makers a concise view of market size, growth direction, clinical demand, technology priorities, competitive intensity, regional opportunity, and the most attractive commercial segments through 2035.

3. U.S. Wearable Neurology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Burden of Chronic Neurological Disorders
3.1.2. Growing Prevalence of Epilepsy and Unmet Seizure-Monitoring Needs
3.1.3. Increasing Parkinson’s Disease and Essential Tremor Population
3.1.4. Expanding Migraine and Chronic Headache Treatment Demand
3.1.5. Rising Stroke, Brain Injury and Neurorehabilitation Requirements
3.1.6. Growth in Alzheimer’s Disease and Cognitive Monitoring Needs
3.1.7. Shift from Episodic Neurological Assessment to Continuous Monitoring
3.1.8. Expansion of Home-Based and Ambulatory Neurological Care
3.1.9. Increasing Demand for Non-Pharmacological Neurological Therapy
3.1.10. Growth of Remote Physiological and Therapeutic Monitoring
3.1.11. Increasing Use of Digital Biomarkers in Neurology Clinical Trials
3.1.12. Neurologist Shortages and Uneven Geographic Access to Specialty Care
3.2. Restraints and Their Impact Analysis
3.2.1. High Device, Software and Recurring Subscription Costs
3.2.2. Inconsistent Insurance Coverage and Reimbursement
3.2.3. Limited Clinical Evidence for Emerging Device Categories
3.2.4. False Alerts and Variable Real-World Algorithm Performance
3.2.5. Patient Adherence, Device Comfort and Charging Burden
3.2.6. Data Privacy and Cybersecurity Concerns
3.2.7. Lack of Interoperability with Electronic Health Records
3.2.8. Clinician Data-Review Burden
3.2.9. Competition from Pharmaceuticals and Conventional Diagnostics
3.3. Opportunities and Their Impact Analysis
3.3.1. Long-Duration Wearable EEG Monitoring
3.3.2. Pediatric Seizure Detection and Caregiver Alerting
3.3.3. Personalized Peripheral Nerve Stimulation
3.3.4. Prescription Migraine and Headache Wearables
3.3.5. Parkinson’s Disease Motor-Fluctuation Monitoring
3.3.6. Wearable Gait, Balance and Fall-Risk Assessment
3.3.7. At-Home Stroke and Brain Injury Rehabilitation
3.3.8. Cognitive Decline and Sleep Pattern Monitoring
3.3.9. Decentralized Clinical Trial Endpoint Development
3.3.10. Pharmaceutical and CRO Partnerships
3.3.11. Subscription-Based Neurological Data Platforms
3.3.12. Rural Neurology and Tele-neurology Expansion
3.4. Challenges and Their Impact Analysis
3.4.1. Differentiating Medical Devices from Consumer Wellness Wearables
3.4.2. Establishing Clinically Meaningful Digital Biomarkers
3.4.3. Maintaining Signal Quality During Long-Term Wear
3.4.4. Managing Algorithm Bias and Patient Variability
3.4.5. Integrating Wearable Data into Existing Neurology Workflows
3.4.6. Achieving Sustainable Patient Engagement
3.4.7. Scaling Clinical Support and Technical Service
3.5. Patent & Innovation Analysis, 2021–2025
3.5.1. Wearable EEG Patent Trends
3.5.2. Seizure Detection Algorithm Patents
3.5.3. Neuromodulation and Electrical Stimulation Patents
3.5.4. Movement Disorder and Gait Analytics Patents
3.5.5. AI and Digital Biomarker Patent Activity
3.6. Clinical Workflow Economics Analysis
3.6.1. Conventional Neurological Assessment Cost Structure
3.6.2. Inpatient Versus Ambulatory EEG Economics
3.6.3. Cost of False Alerts and Unnecessary Escalation
3.6.4. Neurologist and EEG Technologist Productivity
3.6.5. Home Monitoring and Avoided Travel Economics
3.6.6. Rehabilitation Session and Therapist Productivity Economics
3.6.7. Clinical Trial Cost Reduction Potential
3.7. Hospital and Health-System Procurement Behavior Analysis
3.7.1. Clinical Evidence Requirements
3.7.2. Value Analysis Committee Review
3.7.3. Cybersecurity and IT Approval
3.7.4. Pilot Program Design
3.7.5. Workflow Integration Requirements
3.7.6. Total Cost of Ownership Assessment
3.7.7. Enterprise Standardization and Vendor Consolidation

What this section provides: This section explains the clinical, commercial, reimbursement, technological, and operational forces shaping market demand, enabling clients to evaluate growth opportunities, adoption barriers, and execution risks.

4. U.S. Wearable Neurology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitution
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.3.1. Device Acquisition Pricing
4.3.2. Disposable Sensor and Electrode Pricing
4.3.3. Software Subscription Pricing
4.3.4. Per-Patient Monitoring Pricing
4.3.5. Prescription Therapeutic Device Pricing
4.3.6. Clinical Trial and Research Contract Pricing
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Material and Electronic Component Supply
4.4.2. Biosensor and Electrode Development
4.4.3. Device Design and Manufacturing
4.4.4. Software and Algorithm Development
4.4.5. Regulatory and Clinical Validation
4.4.6. Distribution and Prescription Fulfilment
4.4.7. Cloud Monitoring and Data Interpretation
4.4.8. End-User Deployment and Technical Support
4.5. Impact of Digitalization and Connected Neurology
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Medical Device Classification
4.7.2. 510(k) Premarket Notification Pathway
4.7.3. De Novo Classification Pathway
4.7.4. Premarket Approval Considerations
4.7.5. Software as a Medical Device Requirements
4.7.6. AI-Enabled Device Change Management
4.7.7. Human Factors and Usability Requirements
4.7.8. Cybersecurity and Post-Market Surveillance
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Remote Physiological Monitoring
4.8.2. Remote Therapeutic Monitoring
4.8.3. Ambulatory EEG Reimbursement
4.8.4. Durable Medical Equipment Considerations
4.8.5. Medicare Coverage Dynamics
4.8.6. Medicaid Coverage Variability
4.8.7. Commercial Payer Coverage Trends
4.8.8. Out-of-Pocket and Cash-Pay Models
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Public Health Programs
4.11. NIH, Department of Defense and Veterans Affairs Research Influence
4.12. Impact of Escalating Geopolitical Tensions
4.13. Data Privacy, HIPAA and State Privacy Regulation
4.14. Hospital Value Analysis Committee Decision Framework
4.14.1. Clinical Need Assessment
4.14.2. Evidence and Outcomes Review
4.14.3. Economic Impact Analysis
4.14.4. IT and Cybersecurity Review
4.14.5. Operational Readiness Assessment
4.14.6. Patient Safety and Liability Assessment
4.14.7. Pilot-to-Enterprise Adoption Decision

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply chain, digital health, privacy, technology adoption, and hospital procurement dynamics.

5. U.S. Wearable Neurology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Historical and Forecast Market Size, By Product Category, 2021–2035 (US$ Billion)
5.1.3. Product Category Growth and Attractiveness Analysis
5.2. Wearable EEG and Neural Monitoring Systems
5.2.1. Ambulatory EEG Headsets
5.2.2. Reduced-Montage EEG Systems
5.2.3. Adhesive and Extended-Wear Scalp Sensors
5.2.4. Dry-Electrode EEG Headsets
5.2.5. Rapid EEG Assessment Systems
5.2.6. Sleep and Neurophysiological Monitoring Wearables
5.3. Seizure Detection and Caregiver-Alert Wearables
5.3.1. Wrist-Worn Seizure Monitors
5.3.2. Upper-Arm Seizure Monitors
5.3.3. Multimodal Physiological Seizure Detection Devices
5.3.4. Nocturnal Seizure Alert Systems
5.3.5. Pediatric Seizure Monitoring Devices
5.3.6. Cloud-Connected Caregiver Alert Platforms
5.4. Movement, Gait, Tremor and Balance Wearables
5.4.1. Tremor Monitoring Wearables
5.4.2. Parkinson’s Motor-Fluctuation Monitors
5.4.3. Gait and Freezing-of-Gait Sensors
5.4.4. Balance and Fall-Risk Wearables
5.4.5. Instrumented Insoles and Pressure-Sensing Systems
5.4.6. Upper-Limb Movement and Activity Sensors
5.5. Wearable Therapeutic Neuromodulation Devices
5.5.1. Remote Electrical Neuromodulation Devices
5.5.2. External Trigeminal Nerve Stimulation Devices
5.5.3. Non-Invasive Vagus Nerve Stimulation Devices
5.5.4. Transcutaneous Afferent Patterned Stimulation Devices
5.5.5. Transcranial Electrical Stimulation Headsets
5.5.6. Wearable Neuropathic Pain Management Devices
5.6. Neurorehabilitation, Cognitive and Sleep-Related Wearables
5.6.1. Smart Rehabilitation Gloves
5.6.2. Wearable Gait-Training Systems
5.6.3. Upper-Limb Rehabilitation Sensors
5.6.4. Neurofeedback Headsets
5.6.5. Cognitive Monitoring Wearables
5.6.6. Sleep EEG and Neurobehavioral Monitoring Devices

What this section provides: This section identifies the wearable neurology device categories expected to generate the largest revenue contribution, fastest growth, highest recurring revenue, and strongest clinical adoption through 2035.

6. U.S. Wearable Neurology Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Historical and Forecast Market Size, By Application, 2021–2035 (US$ Billion)
6.1.3. Application Growth and Clinical Attractiveness Analysis
6.2. Epilepsy and Seizure Management
6.2.1. Ambulatory EEG Monitoring
6.2.2. Generalized Tonic-Clonic Seizure Detection
6.2.3. Nocturnal Seizure Monitoring
6.2.4. Pediatric Epilepsy Monitoring
6.2.5. Caregiver Alerting and Event Documentation
6.2.6. Drug-Resistant Epilepsy Management
6.3. Parkinson’s Disease, Essential Tremor and Other Movement Disorders
6.3.1. Parkinson’s Disease Motor Monitoring
6.3.2. Essential Tremor Monitoring
6.3.3. Wearable Tremor Therapy
6.3.4. Bradykinesia and Dyskinesia Assessment
6.3.5. Gait and Freezing-of-Gait Monitoring
6.3.6. Dystonia, Ataxia and Other Movement Disorders
6.4. Migraine, Headache and Neuropathic Pain
6.4.1. Acute Migraine Treatment
6.4.2. Preventive Migraine Treatment
6.4.3. Cluster Headache Management
6.4.4. Neuropathic Pain Management
6.4.5. Medication-Alternative Neuromodulation
6.4.6. Pediatric and Adolescent Migraine Management
6.5. Stroke, Traumatic Brain Injury and Neurorehabilitation
6.5.1. Post-Stroke Upper-Limb Rehabilitation
6.5.2. Gait and Mobility Rehabilitation
6.5.3. Balance and Fall-Risk Assessment
6.5.4. Traumatic Brain Injury Assessment
6.5.5. Concussion Monitoring
6.5.6. Home-Based Neurorehabilitation
6.6. Dementia, Cognitive Monitoring, Sleep and Neurobehavioral Applications
6.6.1. Alzheimer’s Disease and Dementia Monitoring
6.6.2. Mild Cognitive Impairment Monitoring
6.6.3. Sleep-Related Neurological Assessment
6.6.4. Neurofeedback and Attention Applications
6.6.5. Depression and Neurobehavioral Neuromodulation
6.6.6. Daily Activity, Wandering and Caregiver-Support Monitoring

What this section provides: This section helps clients understand demand by neurological condition and clinical use case, allowing them to prioritize applications with high patient need, measurable outcomes, reimbursement potential, and technology adoption.

7. U.S. Wearable Neurology Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Historical and Forecast Market Size, By End User, 2021–2035 (US$ Billion)
7.1.3. End-User Adoption and Purchasing Analysis
7.2. Hospitals and Academic Medical Centers
7.2.1. General Hospitals
7.2.2. Teaching Hospitals
7.2.3. Comprehensive Epilepsy Centers
7.2.4. Stroke and Neuroscience Centers
7.2.5. Pediatric Hospitals
7.2.6. Veterans Affairs and Military Medical Centers
7.3. Neurology Clinics and Specialty Care Centers
7.3.1. Epilepsy Clinics
7.3.2. Movement Disorder Clinics
7.3.3. Headache and Migraine Clinics
7.3.4. Sleep Medicine Centers
7.3.5. Memory and Cognitive Care Clinics
7.3.6. Independent Neurology Practices
7.4. Home Healthcare, Patients and Caregivers
7.4.1. Prescription Home Monitoring
7.4.2. Home-Based Therapeutic Neuromodulation
7.4.3. Caregiver-Managed Seizure Detection
7.4.4. Home-Based Parkinson’s Monitoring
7.4.5. Direct-to-Patient Fulfilment
7.4.6. Remote Clinical Support Programs
7.5. Rehabilitation Hospitals and Therapy Providers
7.5.1. Inpatient Rehabilitation Facilities
7.5.2. Outpatient Rehabilitation Centers
7.5.3. Physical and Occupational Therapy Practices
7.5.4. Skilled Nursing Facilities
7.5.5. Home Rehabilitation Providers
7.5.6. Sports Neurology and Concussion Centers
7.6. Pharmaceutical Companies, CROs and Research Institutions
7.6.1. Pharmaceutical and Biotechnology Companies
7.6.2. Contract Research Organizations
7.6.3. Universities and Academic Research Centers
7.6.4. Decentralized Clinical Trial Providers
7.6.5. Government Research Programs
7.6.6. Digital Biomarker Development Organizations

What this section provides: This section explains which care settings, research organizations, patients, and customer groups are expected to drive device purchasing, prescription use, recurring monitoring demand, and clinical-trial deployment.

8. U.S. Wearable Neurology Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Historical and Forecast Market Size, By Technology Type, 2021–2035 (US$ Billion)
8.1.3. Technology Adoption and Innovation Analysis
8.2. EEG and Electrophysiological Signal Technologies
8.2.1. Wet-Electrode EEG
8.2.2. Dry-Electrode EEG
8.2.3. Adhesive EEG Sensors
8.2.4. Reduced-Montage EEG
8.2.5. Electromyography and Muscle-Signal Monitoring
8.2.6. Neurophysiological Signal Processing
8.3. Inertial, Motion and Pressure-Sensing Technologies
8.3.1. Accelerometers
8.3.2. Gyroscopes
8.3.3. Magnetometers
8.3.4. Pressure and Force Sensors
8.3.5. Instrumented Textile Sensors
8.3.6. Gait and Posture Analytics
8.4. Multimodal Physiological Sensor Platforms
8.4.1. Electrodermal Activity Sensors
8.4.2. Photoplethysmography and Heart-Rate Sensors
8.4.3. Skin Temperature Sensors
8.4.4. Oxygen Saturation Sensors
8.4.5. Sleep and Circadian Sensors
8.4.6. Combined Physiological Event-Detection Platforms
8.5. Non-Invasive Electrical Stimulation Technologies
8.5.1. Peripheral Nerve Stimulation
8.5.2. Trigeminal Nerve Stimulation
8.5.3. Vagus Nerve Stimulation
8.5.4. Transcutaneous Afferent Patterned Stimulation
8.5.5. Transcranial Direct Current Stimulation
8.5.6. Transcranial Alternating Current Stimulation
8.5.7. Remote Electrical Neuromodulation
8.6. AI, Cloud Analytics and Digital Biomarker Platforms
8.6.1. AI-Based Seizure Classification
8.6.2. Automated EEG Interpretation
8.6.3. Movement Disorder Analytics
8.6.4. Digital Neurological Biomarkers
8.6.5. Cloud-Based Clinician Dashboards
8.6.6. Patient and Caregiver Mobile Applications
8.6.7. EHR and Clinical Trial Platform Integration

What this section provides: This section evaluates the sensing, stimulation, AI, software, and cloud technologies shaping wearable neurological diagnosis, monitoring, treatment, research, and remote-care workflows.

9. U.S. Wearable Neurology Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Historical and Forecast Market Size, By Procurement Channel, 2021–2035 (US$ Billion)
9.1.3. Procurement Channel Attractiveness Analysis
9.2. Direct Hospital and Health-System Procurement
9.2.1. Capital and Operating Budget Procurement
9.2.2. Department-Level Neurology Procurement
9.2.3. Pilot Program Procurement
9.2.4. Enterprise Software and Monitoring Contracts
9.3. Integrated Delivery Network Enterprise Contracts
9.3.1. Multi-Hospital Standardization
9.3.2. Population Health and Remote Monitoring Contracts
9.3.3. Enterprise Cybersecurity and IT Review
9.3.4. Performance-Based Contracting
9.4. Group Purchasing Organization Contracts
9.4.1. National GPO Agreements
9.4.2. Regional GPO Agreements
9.4.3. Aggregated Purchasing and Pricing Discounts
9.4.4. Formulary and Approved Vendor Inclusion
9.5. Distributor and Specialty Supplier Sales
9.5.1. Neurodiagnostic Equipment Distributors
9.5.2. Durable Medical Equipment Suppliers
9.5.3. Rehabilitation Technology Distributors
9.5.4. Digital Health and Specialty Pharmacy Channels
9.6. Direct Prescription, Patient and Research Procurement
9.6.1. Physician Prescription and Home Delivery
9.6.2. Direct-to-Patient Cash-Pay Sales
9.6.3. Payer-Authorized Device Fulfilment
9.6.4. Pharmaceutical and CRO Research Contracts
9.6.5. University and Government Research Procurement
9.6.6. Subscription and Per-Patient Monitoring Agreements

What this section provides: This section helps clients understand how wearable neurology devices are purchased and deployed in the U.S., including hospital procurement, IDN standardization, GPO influence, prescription fulfilment, direct-to-patient models, and research contracting.

10. U.S. Wearable Neurology Devices Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Neurological Disease Burden Analysis
10.1.4. Regional Hospital, Neurology and Rehabilitation Infrastructure Analysis
10.1.5. Regional Clinical Trial and Neurotechnology Innovation Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Specialist Access and Tele-neurology Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Wearable Neurology Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Wearable Neurology Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Wearable Neurology Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Wearable Neurology Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, neurological care hubs, innovation clusters, access gaps, clinical-trial centers, procurement hotspots, and state-level commercial opportunities.

11. U.S. Wearable Neurology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Product Portfolio Breadth
11.2.2. FDA-Cleared Device Positioning
11.2.3. Clinical Evidence Strength
11.2.4. Software and AI Capabilities
11.2.5. Recurring Revenue Model
11.2.6. U.S. Distribution and Commercial Reach
11.2.7. Pharmaceutical and Research Partnerships
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Strategic Initiatives Analysis
11.4.1. Product Launches
11.4.2. FDA Clearances and Regulatory Expansion
11.4.3. Partnerships and Collaborations
11.4.4. Acquisitions and Portfolio Expansion
11.4.5. Clinical Trial and Research Agreements
11.4.6. Geographic and Distribution Expansion
11.5. Company Profiles
11.5.1. Empatica
11.5.2. Epitel
11.5.3. LivAssured
11.5.4. Ceribell
11.5.5. BrainScope
11.5.6. Cala Health
11.5.7. Theranica
11.5.8. CEFALY Technology
11.5.9. Neurolief
11.5.10. electroCore
11.5.11. NeuroMetrix
11.5.12. NeuroSigma
11.5.13. Great Lakes NeuroTechnologies
11.5.14. Global Kinetics Corporation
11.5.15. Rune Labs
11.5.16. Zeto
11.5.17. Natus Medical
11.5.18. Compumedics
11.5.19. Advanced Brain Monitoring
11.5.20. BioSerenity
11.5.21. EMOTIV
11.5.22. InteraXon
11.5.23. Neuroelectrics
11.5.24. Soterix Medical
11.5.25. Flow Neuroscience

Note: Each company profile will include company overview, wearable neurology device portfolio, target neurological applications, U.S. market strategy, regulatory positioning, technology capabilities, clinical evidence, business model, partnerships, funding or financial positioning, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, regulatory status, innovation direction, business-model intelligence, and strategic analysis of leading wearable neurology device companies.

12. U.S. Wearable Neurology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Extended-Wear and Minimally Obtrusive EEG
12.2.2. Multimodal Seizure Detection
12.2.3. AI-Assisted EEG and Event Interpretation
12.2.4. Personalized Wearable Neuromodulation
12.2.5. Parkinson’s Disease Digital Biomarkers
12.2.6. Closed-Loop Neurological Monitoring and Therapy
12.2.7. Smart Textiles and Skin-Conformal Neural Sensors
12.2.8. Home-Based Robotic and Sensor-Guided Neurorehabilitation
12.2.9. Digital Twins and Predictive Neurological Analytics
12.2.10. Decentralized Neurology Clinical Trials
12.3. Emerging Business Trends
12.3.1. Hardware-as-a-Service Models
12.3.2. Subscription-Based Clinical Analytics
12.3.3. Prescription Digital Therapeutic Integration
12.3.4. Pharmaceutical Companion Technology Partnerships
12.3.5. Outcome-Based Commercial Contracts
12.3.6. Consumer-to-Clinical Data Transition
12.4. Business Opportunities for Startups and Existing Players
12.4.1. Pediatric Neurology
12.4.2. Rural and Underserved Neurology
12.4.3. Senior Care and Cognitive Monitoring
12.4.4. Veterans and Traumatic Brain Injury
12.4.5. Home Rehabilitation
12.4.6. Clinical Trial Data Services
12.5. Investment Prioritization Matrix
12.5.1. Market Attractiveness
12.5.2. Clinical Need
12.5.3. Regulatory Complexity
12.5.4. Reimbursement Readiness
12.5.5. Competitive Intensity
12.5.6. Recurring Revenue Potential

What this section provides: This section prepares clients for future technology shifts, market-structure changes, investment opportunities, emerging commercial models, and alternative adoption scenarios through 2035.

13. U.S. Wearable Neurology Devices Market: Strategic Recommendations

13.1. Recommendations for Wearable Neurology Device Manufacturers
13.1.1. Prioritize Condition-Specific Clinical Utility
13.1.2. Build Regulatory-Grade Evidence Programs
13.1.3. Reduce Clinician Data-Review Burden
13.1.4. Improve Patient Comfort and Adherence
13.1.5. Develop Reimbursement Support Capabilities
13.1.6. Build Cybersecurity and Interoperability Readiness
13.2. Recommendations for Hospitals and Health Systems
13.2.1. Define Target Patient Cohorts
13.2.2. Establish Clinical Ownership and Escalation Pathways
13.2.3. Measure Workflow and Economic Outcomes
13.2.4. Integrate Wearable Data with Existing Systems
13.2.5. Use Structured Pilot-to-Scale Frameworks
13.3. Recommendations for Pharmaceutical Companies and CROs
13.3.1. Select Validated Digital Endpoints
13.3.2. Standardize Device Use Across Trial Sites
13.3.3. Address Missing Data and Patient Adherence
13.3.4. Maintain Longitudinal Device Consistency
13.4. Recommendations for Investors and Private Equity Firms
13.4.1. Assess Regulatory and Clinical Evidence Quality
13.4.2. Evaluate Recurring Revenue Durability
13.4.3. Examine Algorithm and Dataset Defensibility
13.4.4. Prioritize Scalable Clinical Workflows
13.5. Recommendations for Distributors and Channel Partners
13.5.1. Build Neurology-Specific Clinical Support
13.5.2. Expand Prescription and Home-Fulfilment Capabilities
13.5.3. Support Reimbursement Documentation
13.6. Recommendations for New Entrants and Startups
13.6.1. Avoid Undifferentiated General-Purpose Wearables
13.6.2. Target High-Unmet-Need Neurological Conditions
13.6.3. Develop Early FDA and Reimbursement Strategies
13.6.4. Partner with Academic Neurology Centers
13.7. Go-to-Market Strategy Considerations
13.7.1. Clinical Champion Development
13.7.2. Key Opinion Leader Engagement
13.7.3. Pilot Program Design
13.7.4. Specialty Clinic Commercialization
13.7.5. Payer and Employer Engagement
13.7.6. Pharmaceutical Partnership Strategy
13.8. Product Positioning and Portfolio Expansion Guidance

What this section provides: This section converts market intelligence into actionable strategy for product development, clinical validation, reimbursement planning, hospital adoption, channel expansion, investment decisions, and competitive differentiation.

14. U.S. Wearable Neurology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Estimation Limitation
14.4. Forecasting Limitation
14.5. Regulatory and Reimbursement Limitation
14.6. Clinical Use Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer
14.9. Company and Product Information Disclaimer
14.10. Currency and Rounding Disclaimer

What this section provides: This section clarifies the report’s scope, methodological limitations, legal boundaries, clinical-use restrictions, data-use terms, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Wearable Neurology Devices Market: Market Definition and Scope
TABLE 3: U.S. Wearable Neurology Devices Market: Research Methodology Framework
TABLE 4: U.S. Wearable Neurology Devices Market: Key Assumptions
TABLE 5: U.S. Wearable Neurology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Wearable Neurology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Wearable Neurology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Wearable Neurology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Wearable Neurology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Wearable Neurology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Wearable Neurology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Wearable Neurology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Wearable Neurology Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Wearable Neurology Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Wearable Neurology Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Wearable Neurology Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Wearable Neurology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Wearable Neurology Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Wearable Neurology Devices Market: Hospital and Health-System Procurement Behavior Matrix
TABLE 20: U.S. Wearable Neurology Devices Market: PESTEL Analysis
TABLE 21: U.S. Wearable Neurology Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Wearable Neurology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Wearable Neurology Devices Market: Value Chain Analysis
TABLE 24: U.S. Wearable Neurology Devices Market: Supply Chain Analysis
TABLE 25: U.S. Wearable Neurology Devices Market: Digitalization and Connected Neurology Impact
TABLE 26: U.S. Wearable Neurology Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Wearable Neurology Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Wearable Neurology Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Wearable Neurology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Wearable Neurology Devices Market: Government Initiatives and Public Health Programs
TABLE 31: U.S. Wearable Neurology Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Wearable Neurology Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Wearable Neurology Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Wearable Neurology Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Wearable Neurology Devices Market: Wearable EEG and Neural Monitoring Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Wearable Neurology Devices Market: Seizure Detection and Caregiver-Alert Wearables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Wearable Neurology Devices Market: Movement, Gait, Tremor and Balance Wearables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Wearable Neurology Devices Market: Wearable Therapeutic Neuromodulation Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Wearable Neurology Devices Market: Neurorehabilitation, Cognitive and Sleep-Related Wearables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Wearable Neurology Devices Market: Application Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Application
TABLE 44: U.S. Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 45: U.S. Wearable Neurology Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 46: U.S. Wearable Neurology Devices Market: Epilepsy and Seizure Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Wearable Neurology Devices Market: Parkinson’s Disease, Essential Tremor and Other Movement Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Wearable Neurology Devices Market: Migraine, Headache and Neuropathic Pain Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Wearable Neurology Devices Market: Stroke, Traumatic Brain Injury and Neurorehabilitation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Wearable Neurology Devices Market: Dementia, Cognitive Monitoring, Sleep and Neurobehavioral Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Wearable Neurology Devices Market: End User Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by End User
TABLE 53: U.S. Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 54: U.S. Wearable Neurology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 55: U.S. Wearable Neurology Devices Market: Hospitals and Academic Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Wearable Neurology Devices Market: Neurology Clinics and Specialty Care Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Wearable Neurology Devices Market: Home Healthcare, Patients and Caregivers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Wearable Neurology Devices Market: Rehabilitation Hospitals and Therapy Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Wearable Neurology Devices Market: Pharmaceutical Companies, CROs and Research Institutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Wearable Neurology Devices Market: Technology Type Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 62: U.S. Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 63: U.S. Wearable Neurology Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 64: U.S. Wearable Neurology Devices Market: EEG and Electrophysiological Signal Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Wearable Neurology Devices Market: Inertial, Motion and Pressure-Sensing Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Wearable Neurology Devices Market: Multimodal Physiological Sensor Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Wearable Neurology Devices Market: Non-Invasive Electrical Stimulation Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Wearable Neurology Devices Market: AI, Cloud Analytics and Digital Biomarker Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Wearable Neurology Devices Market: Procurement Channel Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 71: U.S. Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 72: U.S. Wearable Neurology Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 73: U.S. Wearable Neurology Devices Market: Direct Hospital and Health-System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Wearable Neurology Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Wearable Neurology Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Wearable Neurology Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Wearable Neurology Devices Market: Direct Prescription, Patient and Research Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Wearable Neurology Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Wearable Neurology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Wearable Neurology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Wearable Neurology Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Wearable Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 84: West Region U.S. Wearable Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 90: California Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 91: California Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 92: California Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 93: California Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 94: California Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 95: Washington Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: Washington Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: Washington Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: Washington Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 99: Washington Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 100: Arizona Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Arizona Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: Arizona Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: Arizona Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 104: Arizona Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Colorado Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 106: Colorado Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Colorado Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: Colorado Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 109: Colorado Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Oregon Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 111: Oregon Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Oregon Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Oregon Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 114: Oregon Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Utah Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Utah Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Utah Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Utah Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Utah Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Nevada Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 121: Nevada Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Nevada Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Nevada Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 124: Nevada Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Idaho Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: Idaho Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Idaho Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Idaho Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: Idaho Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Montana Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 136: Montana Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: Montana Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: Montana Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 139: Montana Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Alaska Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 146: Alaska Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Alaska Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Alaska Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 149: Alaska Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Wearable Neurology Devices Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Wearable Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Northeast Region U.S. Wearable Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: New York Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: New York Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: New York Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: New York Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 167: New York Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: Maine Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 189: Maine Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: Maine Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: Maine Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 192: Maine Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Vermont Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: Vermont Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Vermont Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Vermont Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 197: Vermont Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: Delaware Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 209: Delaware Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 210: Delaware Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 211: Delaware Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 212: Delaware Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Wearable Neurology Devices Market: Regional Overview and Trends
TABLE 214: South Region U.S. Wearable Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 215: South Region U.S. Wearable Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: Texas Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 222: Texas Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 223: Texas Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 224: Texas Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 225: Texas Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 226: Florida Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 227: Florida Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: Florida Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: Florida Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 230: Florida Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: Georgia Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 232: Georgia Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: Georgia Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: Georgia Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 235: Georgia Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: North Carolina Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: Tennessee Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: South Carolina Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: Alabama Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 252: Alabama Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: Alabama Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: Alabama Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 255: Alabama Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: Mississippi Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: Louisiana Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Arkansas Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Kentucky Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Oklahoma Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Virginia Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 282: Virginia Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Virginia Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Virginia Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 285: Virginia Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Maryland Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 287: Maryland Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Maryland Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Maryland Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 290: Maryland Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: Midwest Region U.S. Wearable Neurology Devices Market: Regional Overview and Trends
TABLE 297: Midwest Region U.S. Wearable Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 298: Midwest Region U.S. Wearable Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 299: Midwest Region U.S. Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: Illinois Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 305: Illinois Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Illinois Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 307: Illinois Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 308: Illinois Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: Ohio Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Ohio Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Ohio Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Ohio Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 313: Ohio Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Michigan Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 315: Michigan Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Michigan Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Michigan Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 318: Michigan Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Minnesota Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Indiana Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 325: Indiana Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Indiana Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Indiana Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 328: Indiana Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Wisconsin Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Missouri Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 335: Missouri Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Missouri Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Missouri Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 338: Missouri Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Iowa Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 340: Iowa Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Iowa Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Iowa Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 343: Iowa Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Kansas Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 345: Kansas Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Kansas Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Kansas Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 348: Kansas Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Nebraska Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: North Dakota Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: South Dakota Wearable Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Wearable Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Wearable Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Wearable Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Wearable Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: U.S. Wearable Neurology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 365: U.S. Wearable Neurology Devices Market: Key Company Market Share Analysis, 2025
TABLE 366: U.S. Wearable Neurology Devices Market: Company Positioning Matrix
TABLE 367: U.S. Wearable Neurology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 368: U.S. Wearable Neurology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 369: Empatica: Company Profile
TABLE 370: Epitel: Company Profile
TABLE 371: LivAssured: Company Profile
TABLE 372: Ceribell: Company Profile
TABLE 373: BrainScope: Company Profile
TABLE 374: Cala Health: Company Profile
TABLE 375: Theranica: Company Profile
TABLE 376: CEFALY Technology: Company Profile
TABLE 377: Neurolief: Company Profile
TABLE 378: electroCore: Company Profile
TABLE 379: NeuroMetrix: Company Profile
TABLE 380: NeuroSigma: Company Profile
TABLE 381: Great Lakes NeuroTechnologies: Company Profile
TABLE 382: Global Kinetics Corporation: Company Profile
TABLE 383: Rune Labs: Company Profile
TABLE 384: Zeto: Company Profile
TABLE 385: Natus Medical: Company Profile
TABLE 386: Compumedics: Company Profile
TABLE 387: Advanced Brain Monitoring: Company Profile
TABLE 388: BioSerenity: Company Profile
TABLE 389: EMOTIV: Company Profile
TABLE 390: InteraXon: Company Profile
TABLE 391: Neuroelectrics: Company Profile
TABLE 392: Soterix Medical: Company Profile
TABLE 393: Flow Neuroscience: Company Profile
TABLE 394: U.S. Wearable Neurology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 395: U.S. Wearable Neurology Devices Market: Disruptive Technologies Impact Matrix
TABLE 396: U.S. Wearable Neurology Devices Market: Emerging Business Trends
TABLE 397: U.S. Wearable Neurology Devices Market: Business Opportunities for Startups and Existing Players
TABLE 398: U.S. Wearable Neurology Devices Market: Investment Prioritization Matrix
TABLE 399: U.S. Wearable Neurology Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 400: U.S. Wearable Neurology Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 401: U.S. Wearable Neurology Devices Market: Strategic Recommendations for Pharmaceutical Companies and CROs
TABLE 402: U.S. Wearable Neurology Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 403: U.S. Wearable Neurology Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 404: U.S. Wearable Neurology Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 405: U.S. Wearable Neurology Devices Market: Go-to-Market Strategy Considerations
TABLE 406: U.S. Wearable Neurology Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 407: U.S. Wearable Neurology Devices Market: Scope Limitation
TABLE 408: U.S. Wearable Neurology Devices Market: Data Use Limitation
TABLE 409: U.S. Wearable Neurology Devices Market: Market Estimation Limitation
TABLE 410: U.S. Wearable Neurology Devices Market: Forecasting Limitation
TABLE 411: U.S. Wearable Neurology Devices Market: Regulatory and Reimbursement Limitation
TABLE 412: U.S. Wearable Neurology Devices Market: Clinical Use Limitation
TABLE 413: U.S. Wearable Neurology Devices Market: Legal Disclaimer
TABLE 414: U.S. Wearable Neurology Devices Market: Third-Party Data Disclaimer
TABLE 415: U.S. Wearable Neurology Devices Market: Company and Product Information Disclaimer
TABLE 416: U.S. Wearable Neurology Devices Market: Currency and Rounding Disclaimer

List of Figures

FIGURE 1: U.S. Wearable Neurology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital and Health-System Procurement Decision Framework
FIGURE 12: U.S. Wearable Neurology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Wearable Neurology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Wearable EEG and Neural Monitoring Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Seizure Detection and Caregiver-Alert Wearables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Movement, Gait, Tremor and Balance Wearables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Wearable Therapeutic Neuromodulation Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Neurorehabilitation, Cognitive and Sleep-Related Wearables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Epilepsy and Seizure Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Parkinson’s Disease, Essential Tremor and Other Movement Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Migraine, Headache and Neuropathic Pain Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Stroke, Traumatic Brain Injury and Neurorehabilitation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Dementia, Cognitive Monitoring, Sleep and Neurobehavioral Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 30: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Hospitals and Academic Medical Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Neurology Clinics and Specialty Care Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Home Healthcare, Patients and Caregivers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Rehabilitation Hospitals and Therapy Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Pharmaceutical Companies, CROs and Research Institutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 37: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: EEG and Electrophysiological Signal Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Inertial, Motion and Pressure-Sensing Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Multimodal Physiological Sensor Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Non-Invasive Electrical Stimulation Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: AI, Cloud Analytics and Digital Biomarker Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Direct Hospital and Health-System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Direct Prescription, Patient and Research Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Wearable Neurology Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Wearable Neurology Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Wearable Neurology Devices Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Midwest Region U.S. Wearable Neurology Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Illinois Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Ohio Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Michigan Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Minnesota Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Indiana Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Wisconsin Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Missouri Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Iowa Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Kansas Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Nebraska Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: North Dakota Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: South Dakota Wearable Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 115: Company Positioning Matrix
FIGURE 116: Key Player Product Portfolio Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: Wearable Neurology Device Innovation Roadmap
FIGURE 119: Extended-Wear EEG Adoption Roadmap
FIGURE 120: Multimodal Seizure Detection Opportunity Map
FIGURE 121: Wearable Neuromodulation Growth Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Disruptive Technologies Impact Matrix
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for U.S. Wearable Neurology Device Companies
FIGURE 127: Go-to-Market Strategy Framework
FIGURE 128: Product Positioning and Portfolio Expansion Framework
FIGURE 129: Report Scope and Disclaimer Framework